Work

Immune-related adverse events to predict outcomes in recurrent/metastatic cervical cancer treated with cemiplimab: Insights from a rescue access program in Poland.

Year: 2025

Type: conference-abstract

Study design: Observational Study

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e17504

Authors: Renata Pacholczak-Madej, Maja Lisik-Habib, Radoslaw Madry, Monika Szarszewska, Zuzanna Borysiewicz, Katarzyna Gabalewicz, Ewa Iwańska, Wiktor Szatkowski, Miroslawa Puskulluoglu, Pawel Blecharz

Institutions: The Maria Sklodowska-Curie National Research Institute of Oncology, Copernicus Memorial Hospital, Poznan University of Medical Sciences

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410812696

Cites:

Cited by: 1

Related to: 10